Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Meeder Advisory Services Inc.

Meeder Advisory Services Inc. increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 1.4% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 7,451 shares of the medical research company’s stock after purchasing an additional 104 shares during the period. Meeder Advisory Services Inc.’s holdings in Agilent Technologies were worth $1,106,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of A. Crewe Advisors LLC grew its stake in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory purchased a new position in shares of Agilent Technologies in the 3rd quarter valued at about $28,000. Ridgewood Investments LLC acquired a new position in shares of Agilent Technologies during the second quarter worth about $29,000. Ashton Thomas Securities LLC purchased a new stake in shares of Agilent Technologies during the third quarter worth approximately $31,000. Finally, Fortitude Family Office LLC raised its holdings in Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares in the last quarter.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. This represents a 7.51 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,995 shares of company stock valued at $1,739,510 in the last three months.

Agilent Technologies Price Performance

A opened at $126.92 on Tuesday. Agilent Technologies, Inc. has a 1 year low of $112.39 and a 1 year high of $155.35. The company’s 50 day simple moving average is $138.50 and its 200 day simple moving average is $137.92. The stock has a market capitalization of $36.47 billion, a PE ratio of 26.33, a P/E/G ratio of 5.59 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies’s revenue for the quarter was down 5.6% on a year-over-year basis. During the same quarter last year, the business earned $1.43 EPS. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a $0.236 dividend. The ex-dividend date of this dividend was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.74%. Agilent Technologies’s dividend payout ratio (DPR) is 19.50%.

Analysts Set New Price Targets

A number of equities analysts recently commented on A shares. Evercore ISI boosted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Wells Fargo & Company initiated coverage on Agilent Technologies in a research report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price on the stock. Stifel Nicolaus reiterated a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. TD Cowen boosted their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, Barclays increased their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research report on Tuesday, October 15th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $144.36.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.